DNA methyltransferase 3A (Dnmt3a), a de novo methyltransferase, has attracted a great deal of attention for its important role played in tumorigenesis. We have previously demonstrated that melanoma is unable to grow in-vivo in conditions of Dnmt3a depletion in a mouse model. In this study, we cultured the Dnmt3a depletion B16 melanoma (Dnmt3a-D) cell line to conduct a comparative analysis of protein expression con-comitant with Dnmt3a depletion in a melanoma cell line. After two-dimensional separation, by gel electro-phoresis and liquid chromatography, combined with mass spectrometry analysis (1DE-LC-MS/MS), the re-sults demonstrated that 467 proteins were up-regulated and 535 proteins were down-regulated in the Dnmt3a-D cell line compared to the negative control (NC) cell line. The Genome Ontology (GO) and KEGG pathway were used to further analyze the altered proteins. KEGG pathway analysis indicated that the MAPK signaling pathway exhibited a greater alteration in proteins, an interesting finding due to the close relation-ship with tumorigenesis. The results strongly suggested that Dnmt3a potentially controls the process of tu-morigenesis through the regulation of the proteins (JNK1, p38α, ERK1, ERK2, and BRAF) involved in tu-mor-related pathways, such as the MAPK signaling pathway and melanoma pathway.
Introduction
Malignant melanoma, one of the most aggressive of all skin cancers, exhibits a high skin cancer mortality rate [1] . Upon metastasis, the disease is incurable in most affected people as melanoma does not respond to most systemic treatments and chemotherapy drugs [2] .
It is well established that malignant melanoma contains at least 50 genes that exhibit differential expression as abnormal methylation changes emerge in the promoter region [3] [4] [5] , and that DNA methylation patterns are established and maintained by the coordinated action of three DNA methyltransferases (Dnmts). It has been demonstrated that Dnmt1 [6, 7] , Dnmt3a, and Dnmt3b [8] are over-expressed in many malignant tumors [9] . Dnmt3a plays an important role in epigenetic modification that has attracted a great deal of attention in recent years [10, 11] . It has been reported that epigenetic modification is induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase-Dnmt3a [10] . Additionally, Dnmt3a has been found to maintain DNA methylation and regulate synaptic function in adult forebrain neurons [12] . Furthermore, it has been demonstrated that Dnmt3a-dependent non-promoter DNA methylation facilitates the transcription of neurogenic genes [13] . Recently, studies of Dnmt3a have focused on its effect on proliferation and apoptosis of hepatocellular carcinoma, colorectal cancer and malignant melanoma [14] [15] [16] In a previous study we demonstrated that tumor growth inhibition was mediated by Dnmt3a depletion [17] .
In this study we describe the proteomic experiment and comparative analysis of protein expression in the Dnmt3a depletion B16 melanoma (Dnmt3a-D) cell line. The mouse B16 melanoma cell line used in our study exhibited a specific down-regulation of Dnmt3a via stable transfection using a Dnmt3a-RNAi construct. We obtained the negative control (NC) cell line through use of an unrelated, non-target, shRNA expression vector. Proteins of the NC cell line and Dnmt3a-D cell line were initially separated by one-dimensional gel electrophoresis (1DE), and the two gel tracks were subsequently split into 20 proteome fractions, respectively, and digested by trypsin. The peptide fractions were analyzed by capillary liquid chromatography and high accuracy mass spectrometric acquisition on a LTQ-Orbitrap (Thermo Scientific Germany) in the MS/MS mode using various and complementary fragmentation modes. The results of the comparative proteomics demonstrated that Dnmt3a depletion affects a large number of proteins. The Genome Ontology and KEGG pathway were used to group these altered proteins according to respective cellular components, molecular functions, and pathway. The suppressors of skin tumour development JNK1 and p38α [18] were found to be up-regulated in the MAPK signaling pathway of the Dnmt3a-D cell line. The oncogene BRAF was down-regulated in the melanoma pathway of the Dnmt3a-D cell line. These results strongly suggested that Dnmt3a depletion potentially inhibits melanoma tumorigenesis by regulating the proteins involved in tumorrelated pathways.
Materials and Methods

Cell Culture
The B16 cells were purchased from the American Type Culture Collection (Manassas, VA), cultured in DMEM supplemented with 10% FBS, and maintained in a humidified incubator at 37˚C and 5% CO 2 . The sequence of Dnmt3a shRNA was 5′ gtgcagaaacatcgaggacTTCAAGAGAgtcctcgatgtttctg-cac 3′. A non-target shRNA with the sequence 5′gcaagtctaaccaacgcgt TTCAAGAGAacgcgttggtt -agacttgc 3′ was used as negative control (NC). The process of small hairpin RNA (shRNA) RNAi was performed as previously described [17] . At this point in the procedure we chose the B16 cells with Dnmt3a depletion (Dnmt3a-D) for further experiments.
Protein Extraction and Measurement
After harvesting the cells, the following experimental process was conducted (Figure 1 ). The cells were washed 2-3 times in ice-cold phosphate-buffered saline (PBS), lysed in 900 μL RIPA lysis buffer (Bi Yun Tian Biotechnology Research Institute, China) plus 10 μL 100 mM phenylmethanesulfonyl fluoride (PMSF) for approximately 10 -20 min. The samples were incubated for 2 s in an ice bath and exposed to an ultrasonic power of less than 70 W, and then centrifuged for 45 min at 15,000 rpm at 4˚C. The supernatants were then collected into eppendorf tubes for the next measurement.
The total protein of the cells was measured using the BCA Protein Assay (Bi Yun Tian Biotechnology Research Institute, China) with bovine serum albumin as a standard recommended by the manufacturer. The protein was stored at -80˚C until performance of isoelectro-focusing (IEF).
1-DE and In-Gel Tryptic Digestion
In order to conduct proteomic analysis on proteins expressed at a low level, shotgun proteomics based on 1-DE separation of total protein was evaluated in addition to the analysis of peptide mixtures produced by tryptic digestion of proteins in gel fragments by LC-MS/MS. Equal amounts of NC cell protein and Dnmt3a-D cell protein (40 μg) were prepared in an identical manner. Respective samples were separated using small analytical immobilized pH gradient (IPG) strips (7 cm, 3 -10 pH gradient; Bio-Rad). The proteins were electro-focused by initially using a voltage of 8 V/cm for the stacking gel, and subsequently increasing the voltage to 15 V/cm for the separating gel. Gel lanes were excised from the SDS-PAGE gels using a razor blade and were divided into 20 slices according to the distribution of protein (Figure 2) . The proteins were separated by 12% resolving gel. Each slice was then further divided into approximately 1 mm 3 pieces and placed into an eppendorf tube. The proteins were deoxidized, alkylated, dehydrated and digested. The peptide mixtures were extracted with frequent vortexing at 37˚C for 30 min. Samples were evaporated to dryness and stored at -20˚C until MS analysis.
LC-MS/MS Analysis
In recent years, the high performance and sensitivity of the linear quadrupole ion trap-orbitrap (LTQ-Orbitrap) mass spectrometer has interested researchers due to the capacity for top-down analysis of complete protein from tissue, body fluid, and cells [19, 20] .
The sample was separated using online reverse-phase nanoscale capillary liquid chromatography, and then analyzed by electrospray tandem mass spectrometry. The peptide mixtures loaded and desalted on a C18 trap column (0.5 mm diameter, 2 mm, MICHROM,USA) using a Tempo 1D nanoLC system, then separated on a reversephase MagicTM C18 column (100 µm diameter, 15 cm, MICHROM,USA), using a 120 min linear gradient of mobile phase A (0.875% ACN/0.125% FA/99% H 2 O) at a flow rate of 500 nL/min. The eluent was analyzed on a LTQ-orbitrap mass spectrometer (Thermo Electron, Bremen, Germany) equipped with a heated Desolvation Chamber Interface set to 200˚C and operated using XCalibur software.
The LTQ-orbitrap operated in positive ion mode to survey full scan mass spectra (from m/z 385 to 2000). The most intense ten ions were selected for tandem mass spectrometry and the lock-mass option was used as described in previously published reports [21] .
Identification and Analysis of Proteins
SEQUEST (V.28 (rev.12) 1998-2007) was used to identify proteins based on MS/MS spectra with Bioworks software (Rev.3.3.1 SP1, Thermo Scientific). We searched both forward and reverse sequences against the Swissport Mouse 090303 database in order to estimate the number of identifications that were false-positive in the sample.
The parameters for the SEQUEST search were comprised of the following criteria: Enzyme, trypsin; Missed cleavage sites, 2; fragment tolerance, 1.0 Da; peptide tolerance, 50.00 ppm; Numerical results, 250; Ion and Ion Series Calculated, b ion and y ion; Peptide matches, 10; Report duplicate peptide matches, 10. Oxidation of methionine, methylation of lysine, as well as phosphorylation of serine, threonine, and tyrosine were specified as variable modifications.
We inputted the DAT files from SEQUEST to the Trans-Proteomic Pipeline (TPP) v4.2 JETSTREAM rev 1 (ISB/SPC Proteomics Tools) and searched by allocating all DAT files in the biological sample. The parameters for peptide identification probability and protein identification probability were both set at 0.95.
The results were exported and the proteins found to be altered in the Dnmt3a-D cell line as compared to the NC cell line were extracted by a program developed in-house. GO terms of altered proteins for cellular component and molecular function were searched and checked by Swiss-Prot (http://expasy.org/sprot/), NCBI (http://www. ncbi.nlm.nih.gov) and PIR (http://pir.georgetown.edu/ pirwww/index.shtml). The pathways of altered proteins were established using the KEGG mapper (http://www. genome.jp/kegg/.html). Demonstration of the role of altered proteins in metabolic channels and signal transduction pathways was considered significant.
Results and Discussion
Cell Harvest
Growth conditions of the two cell lines were optimized in our previously reported experiment [17] . Cultured cells were harvested at a confluence level of 90% (Fig-ure 3(a) ).
Western blot analysis was employed to test the efficiency and specificity of the Dnmt3a-RNAi. The results demonstrated that stably transfected B16 Dnmt3a-D cells exhibited a remarkably low level of Dnmt3a expression. No change in Dnmt3a expression was observed in the control NC shRNA transfected cells. The expression of Dnmt3b was not affected in the NC or Dnmt3a-D cells, which is in concordance with our findings in our previous experiment (see Figure 3 (b) in [17] ).
Difference of Protein Expression between NC and Dnmt3a-D Cell Lines
The NC and Dnmt3a-D cell line proteins identified were compared to determine their overlap (Figure 3(b) ). There were 2413 proteins in common between the NC and Dnmt3a-D cell lines, and 467 were unique to the Dnmt3a-D cell line and were considered to be up-regulated proteins in the Dnmt3a-D cell line (Supplementary Materials, Table S1 ). There were 535 proteins unique to the NC cell line considered to be down-regulated proteins in the Dnmt3a-D cell line (Supplementary Materials, Table S2 ). The evidence suggests that Dnmt3a potentially either directly or indirectly regulates the expression of altered proteins.
Genome Ontology of Altered Proteins
In order to evaluate the effect of Dnmt3a depletion on protein expression and to explore the mechanism of Dnmt3a in tumorigenesis, the altered proteins were the principal targets for analysis. The genome ontology cellular localization of altered proteins was as follows: 35% of up-regulated proteins were localized to the cytoplasm, 24% to the nucleus, and 13% to the mitochondrion. The remainder of the up-regulated proteins were classified as golgi, plasma membrane, endoplasmic reticulum, cytoskeleton, extracellular, ribosome, others, and unclassified (28%). The cellular localization of down-regulated proteins was found to be similar to the cellular localization of the up-regulated proteins (Figure 4(a), (b) ). This result demonstrated that the altered proteins are primarily concentrated in the cytoplasm, nucleus, and mitochondria. Among 467 up-regulated proteins, 161 exhibited an activity function (Figure 4(c) ). Among the 535 downregulated proteins, 178 exhibited an activity function (Figure 4(d) ).
There were a large number of altered proteins that exhibited catalytic activity and transferase activity, and they played important roles in the methylation, acetylation, glycosylation, and other epigenetic modifications of the proteins. Another function that attracted our attention was phosphotransferase activity, which is essential for protein phosphorylation. It is well understood that protein phosphorylation is closely related to a variety of biological processes, such as DNA damage and repair [22] , transcriptional regulation [23] , signal transduction, and the regulation of apoptosis [24, 25] .
Pathway of Altered Proteins
The altered proteins were grouped according to their respective KEGG pathway ( Figure 5 ). The pathways were arranged according to the number of altered proteins. The pathways that included less than 10 altered proteins were not shown. The four pathways with the largest number of altered proteins were metabolic pathways (71 proteins), endocytosis (21 proteins), mitogen activated protein kinase signaling pathway (MAPK signaling pathway, 19 proteins) and pathways in cancer (17 proteins) . Among these four pathways, the MAPK signaling pathway, closely related to the cancer and melanoma pathway, and which plays a key role in melanoma tumorigenesis, attracted our attention. The locations of altered proteins in the two pathway maps were established using the KEGG mapper.
MAPK Signaling Pathway
The altered proteins involved in the MAPK signaling pathway are listed in Table 1 . The locations of the altered proteins involved in the MAPK signaling pathway are marked by pink boxes (up-regulated proteins) and yellow boxes (down-regulated proteins) as shown in Figure 6 . The MAPKs belong to a family of highly conserved kinases that convert extracellular signals to intracellular responses. MAPKs are unique to eukaryotes and are important signal transducing enzymes regulated by a phosphorylation cascade. Two upstream protein kinases are activated in the series that leads to the activation of a MAP kinase; additional kinases may also be required upstream of this three-kinase module. After activation, MAPKs phosphorylate specific serine and threonine residues of target substrates, including other protein kinases and many transcription factors. MAPKs are switched off by both generic phosphatases and dualspecificity phosphatases and are further regulated by scaffold proteins, which are usually specific for each of the three major mammalian MAPK pathways, including extracellular signal-regulated kinase (ERK), c-Jun Nterminal kinase (JNK), and p38 MAPK [18, 26, 27 ]. In recent years, it has been demonstrated that the MAPK signaling pathway plays a key role in the cell cycle and gene expression regulation of various cells. MAP kinases are major components of the pathways that control embryogenesis, cell differentiation, cell proliferation, and cell death. Current research on the three pathways is described in detail, and offers insight into the mechanism of the pathways. Much of the review highlights research into the JNK and p38 MAPK pathways, stress activated protein kinase pathways that are also often deregulated in cancer. JNKs and p38 MAPKs are activated by environmental and genotoxic stress and are associated with tumorigenesis in humans and mice. The function of JNKs and p38 MAPKs in cancer development are complex and correlate with the wide range of cellular responses that they modulate [28,29].
JNK Pathway
Three genes encode the JNK proteins: MAPK8 encodes JNK1/ MAPK8, MAPK9 encodes JNK2/ MAPK9, and MAPK10 encodes JNK3/ MAPK10 [30] . Various JNKs differ substantially in their ability to interact with JUN, a well-established regulator of cell cycle progression [31] . A JNK2 deficiency results in elevated c-Jun phosphorylation and stability, whereas the absence of JNK1 reduces c-Jun phosphorylation and stability. JNK2 preferentially binds to c-Jun in unstimulated cells, thereby contributing to c-Jun degradation. In contrast, JNK1 becomes the major c-Jun interacting kinase after cell stimulation [32] . It has been recently demonstrated that the JNK pathway is linked to p53-dependent senescence via a conditional JNK1 allele [33] . The contribution of JNK1 to tumour development has also been investigated in mouse skin carcinogenesis. JNK1-knockout mice were shown to be more susceptible to tumours of the skin [34] . These results indicate that JNK1 may act as a suppressor of skin tumour development. In this study, JNK1 was found to be up-regulated in the Dnmt3a-D cell line which is unable to grow in-vivo, which potentially illustrates the fact that Dnmt3a depletion affects melanoma tumorigenesis by regulation of JNK1 expression.
p38 MAPK Pathway
The p38 MAPKs are activated by the upstream MKK3 and MKK6 kinases as shown in Figure 6 . There are four genes that encode p38 MAPKs: MAPK14 encodes p38α/MAPK14; MAPK11 encodes p38β/MAPK11; MA-PK12 encodes p38γ/MAPK12; and MAPK13 encodes p38δ/MAPK13 [35] . Among these, p38α was found to be up-regulated in the Dnmt3a-D cell line. Most of the published studies that have investigated p38 MAPKs refer to p38α, as p38α was highly abundant in most cell types [36] . A stress-activated protein kinase, p38α suppresses tumor formation by negatively regulating cell cycle pro-gression and proliferation, or by inducing apoptosis [37] [38] [39] [40] .
There is evidence that indicates that p38α also may be an important regulator of differentiation programs in many cell types, including epithelial lung cells and embryonic stem cells [41, 42] . Moreover, p38α directly phosphorylates and modulates the activity of several transcription factors involved in tissue-specific differentiation. The differentiation-inducing activity of p38α may be related to tumour suppression, as p38α activation triggers a high level of specific differentiation and lowers transformed phenotypes in renal carcinoma and colon cancer cell lines compared to cancer cell lines in which p38α has not been activated [43] [44] [45] . The function of p38α as a tumour suppressor in-vivo has been observed in a mouse model [18] . These results provide a reasonable explanation as to why the Dnmt3a-D cell line with p38α up-regulated is unable to grow in-vivo. Dnmt3a depletion potentially directly or indirectly regulates the expression of p38α.
ERK Pathway
ERK1 and ERK2 are ubiquitously expressed, although their relative abundance in tissues is variable. They are stimulated to a certain extent by a vast number of ligands and cellular perturbations, and there is evidence of some cell type specificity [46] . They are highly expressed in postmitotic neurons and other highly differentiated cells [47] , and in these cells they are often involved in adaptive responses, such as long-term potentiation [48, 49] . The receptor tyrosine kinase uses the ERK1 and ERK2 cell membrane signaling pathway [50] [51] [52] . Stimulation of these receptors by the appropriate ligand results is an increase in the catalytic activity of the receptor and subsequent autophosphorylation on tyrosine residues. Phosphorylation of these receptors results in the formation of multiprotein complexes whose organization dictates further downstream signaling events.
The ERK pathway is a major pathway involved in the control of growth signals, cell survival, and invasion.
ERK acts as a central point where multiple signaling pathways coalesce to drive transcription, and it plays a critical role in the pathway downstream of Ras, Raf, and MEK. Melanomas are known to harbour activation mutations for both Ras and BRAF, suggesting that the downstream effector ERK may be playing a key role in the oncogenic behaviour of these tumours. In-vitro studies have demonstrated that melanoma cell lines and tumour tissues exhibit high constitutive ERK activity. The high constitutive ERK activity in melanoma is most likely a consequence of mutations in the upstream components of the MAPK pathway [53, 54] . In this study, we found that tumour cells cannot grow normally with ERK1 and ERK2 up-regulated while upstream components B-raf are concurrently down-regulated. Accordingly, we suspected that the activity of ERK1 and ERK2 was limited by the down-regulation of upstream components B-raf. This may account for the ability of Dnmt3a to affect the growth of melanoma by regulating the activity of ERK.
Melanoma Pathway
The altered proteins involved in the melanoma pathway are listed in Table 2 . The locations of the altered proteins involved in the melanoma pathway are indicated with pink boxes (up-regulated proteins) and yellow boxes (down-regulated proteins) in Figure 7 . The figure was manually edited. BRAF plays an important role in replicative and oncogene-induced senescence, as indicated by the red oval.
Frequent somatic mutation of BRAF is described in melanoma cell lines, such as the B16 mouse melanoma cell line, and other tumors [55, 56] . BRAF is a serine/ threonine kinase that is commonly activated by a somatic point mutation in human cancer, and may provide new therapeutic opportunities for malignant melanoma [57] . Thus, we focused on BRAF in the melanoma pathway.
It has been reported that PTEN deficiency combined with BRAF activation induces a melanoma in-situ like phenotype without dermal invasion [58] . In our study, BRAF was found to be down-regulated in the melanoma pathway of the Dnmt3a-D cell line (Figure 7) . Most likely, the down-regulated expression of BRAF resulted in the suppression of tumorigenesis. Dnmt3a depletion inhibited the growth of melanoma by directly or indirectly regulating the expression of BRAF.
Conclusions
This study demonstrates the varied changes in protein level, and that in the Dnmt3a-D cell line 467 proteins were up-regulated, while 535 proteins were down-regulated as compared to the NC cell line. GO analysis indicated that the altered proteins were primarily concentrated in the cytoplasm, nucleus, and mitochondrion, and that the altered proteins exhibiting activity function were primarily classified as exhibiting catalytic activity, transferase activity, and phosphotransferase activity. KEGG pathway analysis demonstrated that the MAPK signaling pathway exhibited a greater level of altered proteins, a fact that attracted our attention due to the close relationship with tumorigenesis. Taken together, our results strongly suggested that Dnmt3a depletion has a great impact on the expression of melanoma cell proteins. Additionally, Dnmt3a depletion may affect tumorigenesis through regulation of the proteins involved in tumorrelated pathways, such as the MAPK signaling pathway and the melanoma pathway. These results indicated that the tumor-related pathways may be potentially valuable for the treatment of malignant melanoma in the future.
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